These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37952972)

  • 1. Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma.
    Toyoda H; Tani A; Goto-Koshino Y; Motegi T; Sakamoto M; Mochizuki T; Harada K; Kobayashi T; Setoguchi A; Shizuta Y; Mizuno T; Irie M; Nakamichi J; Tsujimoto H; Ohmi A; Fukuoka R; Nakamura Y; Tomiyasu H
    J Vet Med Sci; 2024 Jan; 86(1):18-27. PubMed ID: 37952972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA profiling in canine multicentric lymphoma.
    Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
    PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy.
    Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    J Vet Intern Med; 2011; 25(2):292-6. PubMed ID: 21314721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
    Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    J Vet Intern Med; 2011; 25(2):285-91. PubMed ID: 21314729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
    Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
    Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-Seq analysis of gene expression in 25 cases of canine lymphoma undergoing CHOP chemotherapy.
    Mee MW; Faulkner S; Wood GA; Woods JP; Bienzle D; Coomber BL
    BMC Res Notes; 2022 Mar; 15(1):111. PubMed ID: 35317846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response-based modification of CHOP chemotherapy for canine B-cell lymphoma.
    Benjamin SE; Sorenmo KU; Krick EL; Salah P; Walsh KA; Weinstein NM; Keuler NS; Avery AC; Atherton MJ; Lenz JA
    Vet Comp Oncol; 2021 Sep; 19(3):541-550. PubMed ID: 33729654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
    Wang SL; Lee JJ; Liao AT
    Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of gene expression profiles reveals novel candidates of chemotherapy resistant factors in canine lymphoma.
    Suenaga M; Tomiyasu H; Watanabe M; Ogawa K; Motegi T; Goto-Koshino Y; Ohno K; Sugano S; Skorupski KA; Tsujimoto H
    Vet J; 2017 Oct; 228():18-21. PubMed ID: 29153103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocol.
    Wolf-Ringwall A; Lopez L; Elmslie R; Fowler B; Lori J; Sfiligoi G; Skope A; Arnold E; Hughes KL; Thamm DH; Ehrhart EJ; Avery AC; Lana SE
    Vet Comp Oncol; 2020 Sep; 18(3):342-352. PubMed ID: 31682319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
    Hahn KA; Richardson RC; Teclaw RF; Cline JM; Carlton WW; DeNicola DB; Bonney PL
    J Vet Intern Med; 1992; 6(1):3-10. PubMed ID: 1548624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a scoring system to predict resistance to chemotherapeutic drugs using gene expression profiles in canine lymphoma.
    Tani A; Saegusa Y; Ogawa K; Tomiyasu H; Takeuchi Y; Harada K; Kobayashi T; Setoguchi A; Nakamichi J; Mizuno T; Irie M; Tokita M; Fujita K; Suenaga M; Motegi T; Ohmi A; Goto-Koshino Y; Ohno K; Tsujimoto H
    Res Vet Sci; 2021 Jul; 137():208-216. PubMed ID: 34020336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a CHOP-LAsp-based protocol with and without maintenance for canine multicentric lymphoma.
    Lautscham EM; Kessler M; Ernst T; Willimzig L; Neiger R
    Vet Rec; 2017 Mar; 180(12):303. PubMed ID: 28100766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma.
    Al-Nadaf S; Rebhun RB; Curran KM; Venable RO; Skorupski KA; Willcox JL; Burton JH
    BMC Vet Res; 2018 Nov; 14(1):356. PubMed ID: 30458771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study.
    Baskin CR; Couto CG; Wittum TE
    J Am Anim Hosp Assoc; 2000; 36(5):404-9. PubMed ID: 10997515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole genome sequencing analysis of high confidence variants of B-cell lymphoma in Canis familiaris.
    Sparks A; Woods JP; Bienzle D; Wood GA; Coomber BL
    PLoS One; 2020; 15(8):e0238183. PubMed ID: 32857815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.